Introduction {#h0}
============

*Bacillus anthracis* is a Gram-positive, aerobic soil bacterium that forms durable spores upon nutrient deprivation, and contact with these spores causes the potentially lethal disease anthrax in animals and humans ([@B1]). Formation of *B. anthracis* spores begins with an asymmetric septation that divides the vegetative cell into a mother cell compartment and a smaller forespore compartment, which is followed by engulfment of the forespore by the mother cell. Three protective layers called the cortex, coat, and exosporium then surround the forespore prior to mother cell lysis ([@B2]). The outermost exosporium layer, which appears to be separated from the underlying coat, is a bipartite structure consisting of a paracrystalline basal layer and an external hairlike nap ([@B3]). The filaments of the nap are formed by trimers of the collagenlike glycoprotein BclA ([@B4]--[@B6]). Recent studies suggest that BclA plays a key role in pathogenesis by promoting spore uptake by host professional phagocytic cells that carry the spores to internal tissues, where spore germination and bacterial cell growth can occur ([@B7], [@B8]). The basal layer of the exosporium contains approximately 20 different proteins, including a protein called BxpB ([@B9]). BxpB (also called ExsFA) is required for the attachment of approximately 98% of the total BclA present in the exosporium ([@B10], [@B11]). Attachment of the remaining BclA requires the BxpB paralog ExsFB ([@B11]).

BclA is composed of three domains: a 38-residue amino-terminal domain (NTD), an extensively glycosylated collagenlike region containing a strain-specific number of GX~1~X~2~ (mostly GPT) triplet amino acid repeats, and a 134-residue carboxy-terminal domain ([@B5], [@B6], [@B9]). Basal layer attachment of BclA occurs through its NTD ([@B4], [@B12]), and this attachment requires proteolytic cleavage of the NTD between residues S19 and A20 ([@B13]). BclA attachment also involves a region of the NTD between residues 21 and 33 that includes at least one signal for the localization of BclA to the forespore ([@B13]). Proteolytic cleavage preceding NTD residue A20 occurs only after BclA is bound to the developing forespore ([@B12]). In mature spores, BclA is included in high-molecular-mass (\>250-kDa) complexes that also include BxpB and in some cases other exosporium proteins, such as ExsY and its homolog CotY ([@B10], [@B13], [@B14]). These complexes are stable under conditions designed to dissociate noncovalently bound protein complexes and to reduce disulfide bonds ([@B13]). Furthermore, BclA is unable to form disulfide bonds with other proteins because it does not contain cysteine residues. Recently, we proposed a model for BclA attachment to the exosporium basal layer in which NTD residue A20 is linked to BxpB through an unspecified covalent bond ([@B13]).

In this study, we demonstrate that the attachment of BclA involves the formation of isopeptide bonds between the amino group of residue A20 of proteolytically processed BclA and the side chain carboxyl group of 1 of 10 acidic residues of BxpB. The formation of these isopeptide bonds appears to occur through a mechanism unlike any known mechanism of protein cross-linking through isopeptide bond formation. We also discuss the possibility that the mechanism used for BclA attachment to BxpB represents a new general mechanism for the attachment and cross-linking of proteins.

RESULTS {#h1}
=======

BclA is attached to BxpB through promiscuous formation of isopeptide bonds. {#h1.1}
---------------------------------------------------------------------------

To test and clarify the model that the amino terminus of cleaved BclA is covalently attached to BxpB, we prepared purified exosporia from spores of the *B. anthracis* Sterne strain. The Sterne strain is avirulent due to its inability to produce a capsule on vegetative cells; however, the exosporium of Sterne spores is essentially identical to the exosporium produced by virulent *B. anthracis* strains ([@B14]). The purified exosporia were incubated under denaturing and reducing conditions to solubilize exosporium proteins and protein complexes, which were separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). The \>250-kDa complexes containing BclA and BxpB were excised from the gel and treated *in situ* with trypsin and chymotrypsin ([@B15]). Trypsin and chymotrypsin cleave BxpB at many sites, but only chymotrypsin cleaves the NTD of BclA; one of the chymotrypsin cleavage sites of the NTD is between residues F21 and D22. Therefore, according to our model, trypsin and chymotrypsin treatment of BclA-BxpB covalent complexes should produce peptides with the BclA dipeptide containing residues A20 and F21 (AF peptide) linked to an amino acid within a proteolytic fragment of BxpB. To identify these peptides, the proteolytic fragments of the \>250-kDa complexes were separated by liquid chromatography (LC) and the major fragments were sequenced by tandem mass spectrometry (MS/MS). The attachment of an AF peptide to a particular amino acid was detected as an increase of 218.1 Da in the expected mass of that amino acid.

Many proteolytic fragments containing only BclA, BxpB, ExsY, or CotY sequences were identified. In addition, eight BxpB fragments with one or two attached AF peptides were identified ([Table 1](#t1){ref-type="table"}). The MS/MS spectrum of one of these fragments is shown in [Fig. 1](#f1){ref-type="fig"}. In each of the eight compound fragments, the AF peptide was attached to an internal acidic (D or E) residue of BxpB, which was accompanied by the loss of mass of one water molecule. This result indicated the formation of an isopeptide bond between the amino group of BclA residue A20 and a side chain carboxyl group of BxpB. The attachment of an AF peptide occurred at 8 of the 13 acidic residues of BxpB, which contains 167 amino acids ([@B9]). Comparing independently derived fragments containing the same BxpB residues showed that a particular acidic residue might be involved in an isopeptide bond in one fragment but not in another ([Table 1](#t1){ref-type="table"}), indicating a somewhat random pattern of AF peptide attachment. On the other hand, none of the acidic residues near the amino terminus of BxpB (i.e., D5, E7, D12, and E14) participated in the formation of an isopeptide bond with BclA.

![Positive-ion MS/MS spectrum used to determine the sequence of a branched peptide containing BxpB residues 60 to 69 with AF peptides derived from the NTD of BclA attached to residues D60 and D66. The spectrum was produced by electrospray ionization collision-activated dissociation of (M+ 2 H)^2+^ ions (*m/*z = 728.2). Fragmentation endpoints of y ions and b ions are indicated on the peptide sequence. Ion labels and their meanings are as follows: \*, loss of ammonia; °, loss of water; F, loss of phenylalanine due to cleavage of the AF peptide bond; AF, loss of AF peptide due to cleavage of the isopeptide bond; multiple \* and/or ° symbols, multiple losses of ammonia and/or water.](mbo0031111220001){#f1}

###### 

BxpB fragments with attached AF peptides derived from BclA

  BxpB residues   BxpB sequence*^[a](#ngt1.1)^*
  --------------- -------------------------------
  53--69          ITVPVINDTVSVG**D**GIR
  60--69          **D**TVSVG**D**GIR
  87--97          **D**NSPVAPEAGR
  87--98          **D**NSPVAP**E**AGRF
  92--97          AP**E**AGR
  118--134        SNVIGTGEV**D**VSSGVIL
  118--134        SNVIGTG**E**V**D**VSSGVIL
  145--157        IVPV**E**LIGTV**D**IR

 AF peptide attachment sites are in bold.

Up to three BclA NTDs are attached to a single BxpB molecule. {#h1.2}
-------------------------------------------------------------

To further investigate the mechanism of BclA attachment to BxpB, we expressed a plasmid-encoded BclA NTD-enhanced green fluorescence protein (eGFP) fusion protein in BclA-deficient *B. anthracis* strain CLT360 (*∆bclA ∆rmlD*)/pCLT1525 ([@B13]). (Note that the *∆rmlD* mutation in this strain prevents rhamnose biosynthesis and stabilizes the fusion protein on the spore surface for unknown reasons.) The BclA NTD directs stable attachment of the fusion protein to the exosporium basal layer of spores produced by this strain ([@B12], [@B13]). Exosporia were purified from these spores, exosporium protein complexes were separated by SDS-PAGE as described above in duplicate gels, and protein bands in the gels were analyzed by immunoblotting with either an anti-BxpB monoclonal antibody (MAb) ([@B13]) or a commercially available anti-eGFP MAb. We detected three major eGFP-containing protein bands with apparent molecular masses large enough to contain fusion protein-BxpB complexes, which have a minimum calculated molecular mass of 46.5 kDa. These protein bands had apparent molecular masses of 55, 90, and 130 kDa and were designated bands 1, 2, and 3, respectively ([Fig. 2](#f2){ref-type="fig"}). The relative levels of anti-eGFP MAb staining of these three bands were 1 \> 2 \>\> 3. Using densitometry, we measured the intensities of staining of each band with the anti-BxpB and anti-eGFP MAbs and calculated the relative amounts of BxpB and eGFP in each band. These results indicated that bands 1, 2, and 3 contained one, two, and three fusion proteins per molecule of BxpB, respectively. Based on their apparent molecular masses, and assuming slightly slower gel mobility due to a branched protein structure, our results suggest that the complexes in bands 1, 2, and 3 contain a single molecule of BxpB.

![Exosporium protein complexes containing BclA NTD-eGFP fusion protein(s) attached to BxpB. After separation by SDS-PAGE, protein complexes were visualized by staining with Coomassie blue and analyzed by immunoblotting with anti-GFP and anti-BxpB MAbs. Bands 1, 2, and 3 include complexes with BxpB attached to one, two, and three molecules of the BclA NTD-eGFP fusion protein, respectively. Gel locations and molecular masses of prestained protein standards are shown. The bands in the anti-GFP lane with apparent masses of approximately 30 kDa or less presumably contain free fusion protein or products of fusion protein degradation. The bands in the anti-BxpB lane with apparent masses less than that of band 1 presumably contain BxpB complexes with other basal layer proteins or free BxpB, which has a mass of 17.3 kDa.](mbo0031111220002){#f2}

To substantiate these conclusions, protein bands 1 and 2 were individually digested with trypsin and chymotrypsin and the resulting peptides were separated and sequenced by LC-MS/MS as described above. Eighteen BxpB fragments with attached AF peptides derived from the BclA NTD-eGFP fusion protein were identified ([Table 2](#t2){ref-type="table"}). Sixteen fragments---seven from band 1 and nine from band 2---contained a single AF peptide. The remaining two fragments contained two AF peptides, and both of these fragments were obtained from band 2. These results are consistent with the prediction that bands 1 and 2 contain BxpB-(BclA NTD-eGFP) and BxpB-(BclA NTD-eGFP)~2~ complexes, respectively. Furthermore, the analysis of the fragments from bands 1 and 2 showed that the attachment of AF peptides occurred at eight different BxpB residues, six acidic residues identified in [Table 1](#t1){ref-type="table"} along with residues E7 and D141.

###### 

BxpB fragments with attached AF peptides derived from a BclA NTD-eGFP fusion protein

  BxpB residues   BxpB sequence*^[a](#ngt2.1)^*    Band source(s)
  --------------- -------------------------------- ----------------
  1--10           MFSSDC**E**FTK                   1, 2
  44--69          LPSVSPNPNITVPVINDTVSVG**D**GIR   1
  83--97          TISL**D**NSPVAPEAGR              2
  83--98          TISL**D**NSPVAPEAGRF             1
  87--97          DNSPVAP**E**AGR                  2
  87--98          **D**NSPVAPEAGRF                 2
  87--98          DNSPVAP**E**AGRF                 2
  87--98          **D**NSPVAP**E**AGRF             2
  118--134        SNVIGTGEV**D**VSSGVIL            2
  118--137        SNVIGTG**E**VDVSSGVILINL         2
  118--138        SNVIGTG**E**VDVSSGVILINLN        2
  118--138        SNVIGTGEV**D**VSSGVILINLN        1
  118--142        SNVIGTG**E**VDVSSGVILINLNPGDL    1
  120--137        VIGTG**E**V**D**VSSGVILINL       2
  120--142        VIGTGEV**D**VSSGVILINLNPGDL      2
  138--144        NPG**D**LIR                      1
  151--157        IGTV**D**IR                      1

 AF peptide attachment sites are in bold.

Taken together, the results of the analyses of fragments derived from both the BxpB-BclA and BxpB-(BclA NTD-eGFP) complexes indicate that up to three BclA NTDs can be attached through isopeptide bonds to a single molecule of BxpB. However, attachment of multiple NTDs to a single BxpB proteolytic fragment containing at least two acidic residues was much more frequent when the NTD was derived from BclA. The frequency of multiple attachments was 57% with BclA, compared to 18% with BclA NTD-eGFP (considering only fragments derived from band 2). This difference might be due to the fact that BclA is attached as a trimer while the fusion protein is presumably attached as a monomer. The covalent attachment of one strand of the BclA trimer to BxpB could facilitate the attachment of the second and third strands of this trimer to nearby BxpB acidic residues. Such a model is consistent with the observation that multiple BclA NTDs are readily attached to neighboring BxpB acidic residues ([Table 1](#t1){ref-type="table"}) and with the fact that less than 10% of the BclA extracted from spores is monomeric ([@B13]).

Ten of the 13 acidic residues of BxpB are potential sites for BclA attachment. {#h1.3}
------------------------------------------------------------------------------

The results shown in [Tables 1](#t1){ref-type="table"} and [2](#t2){ref-type="table"} demonstrate that BclA NTD attachment can occur at 10 of the 13 widely scattered acidic residues of BxpB. Attachment to BxpB amino-terminal residues D5, D12, and E14 was not detected, although numerous BxpB fragments including these residues were identified by LC-MS/MS. To further investigate the selection of BclA attachment sites, we constructed a series of plasmids capable of expressing, from the *bxpB* promoter, wild-type BxpB and BxpB mutant proteins in which selected acidic residues were changed to alanines. The mutations included changing all 13 acidic residues (designated 13M), changing all acidic residues except D5, D12, and E14 (designated 10M), and changing all acidic residues except D5, D12, E14, and 1 of the other 10 D/E residues (designated 10M plus the other retained D/E residue). The expression plasmids were individually introduced by transformation into a *∆bxpB* variant of the Sterne strain (CLT307), and the formation of \>250-kDa complexes containing BclA and BxpB was examined during sporulation. These complexes were detected by immunoblotting with an anti-BclA MAb ([Fig. 3](#f3){ref-type="fig"}), and the presence of wild-type or mutant BxpB protein was confirmed by immunoblotting with an anti-BxpB MAb (data not shown) ([@B13]) or by MS/MS analysis of proteolytic fragments as described above, respectively.

![Acidic residues of BxpB that can serve as sites for covalent attachment of BclA. Formation of \>250-kDa BclA/BxpB-containing exosporium protein complexes formed by the indicated strains was detected by immunoblotting with an anti-BclA MAb. The strains examined were Sterne (wild type \[WT\]), a Sterne mutant lacking *bxpB* (*∆bxpB*), and variants of the *∆bxpB* mutant that carried a plasmid directing the correctly timed expression of wild-type BxpB (pWT) and the indicated mutant BxpB proteins. In the 10M mutant protein, all acidic residues except D5, D12, and E14 were changed to alanines; in the 10M+D/E mutant proteins, all acidic residues except D5, D12, E14, and the indicated D/E residue were changed to alanines. Only the part of the immunoblot containing bands is shown, and the gel locations and molecular masses of prestained protein standards are indicated. The arrowhead points to the band containing glycosylated monomeric BclA, and the brace marks the \>250-kDa BclA/BxpB-containing complexes ([@B13]).](mbo0031111220003){#f3}

In the case of the 13M and 10M mutants, only background levels of \>250-kDa complexes equal to that observed with a *∆bxpB* variant of the Sterne strain were detected ([Fig. 3](#f3){ref-type="fig"} and data not shown). Presumably, this background was due to low-level BclA attachment to the BxpB paralog ExsFB. The failure to detect BclA attachment to the 10M mutant, which did not appear to be due to mutant protein instability (see below), provided direct evidence that BxpB residues D5, D12, and E14 cannot participate in BclA attachment. In contrast, \>250-kDa complexes above background levels were detected when every other mutant BxpB protein was expressed ([Fig. 3](#f3){ref-type="fig"}), confirming that all BxpB D/E residues other than D5, D12, and E14 are potential sites for BclA attachment. However, the level of BclA attachment to individual D/E residues was highly variable, suggesting preferred sites. The highest levels of attachment were observed at residues E125 and D127, which were approximately one-third of the level observed with wild-type BxpB ([Fig. 3](#f3){ref-type="fig"}). To confirm that attachment of BclA to the 10M+D/E mutant proteins occurred through isopeptide bonds, we analyzed the \>250-kDa complexes formed by the 10M+E125 mutant by LC-MS/MS as described above. A branched peptide in which an AF peptide was cross-linked to residue E125 was identified. Furthermore, we identified several branched peptides in which an AF peptide derived from the the BclA NTD-eGFP fusion protein was cross-linked to residue E125 of the 10M+E125 mutant BxpB protein (data not shown).

BclA-BxpB isopeptide bonds form spontaneously *in vitro*. {#h1.4}
---------------------------------------------------------

To examine the possibility that BclA and BxpB form isopeptide bonds without the participation of other proteins, we synthesized amino-terminally His~6~-tagged versions of BclA and BxpB in *Escherichia coli* and purified each recombinant protein by affinity chromatography ([@B9], [@B10]). The His~6~ tag was removed from recombinant BxpB (rBxpB) ([@B10]). The two proteins were combined at µM concentrations in phosphate-buffered saline and incubated at room temperature for 30 min. After separation by SDS-PAGE, stable and high-molecular-mass complexes containing both recombinant BclA (rBclA) and rBxpB were detected by immunoblotting individually with anti-BclA and anti-BxpB MAbs and by staining with Coomassie blue ([Fig. 4](#f4){ref-type="fig"}). These complexes were excised from a polyacrylamide gel and treated *in situ* with trypsin and chymotrypsin, and the proteolytic fragments were analyzed by LC-MS/MS as described above. A total of 32 branched peptides were identified in which a peptide derived from the amino-terminal region of rBclA (either GSSHHHHHHSSGL or GSSHHHHHHSSGLVPR; residues 2 to 14 or 2 to 17, respectively) was attached to one or two internal acidic residues of a proteolytic fragment of rBxpB ([Table 3](#t3){ref-type="table"}). Again, this attachment was accompanied by the loss of mass of one water molecule, consistent with isopeptide bond formation. In these branched peptides, isopeptide bonds were apparently formed between the amino group of rBclA residue G2 and the side chain carboxyl groups of any of the 13 acidic residues of rBxpB. Presumably, the initiating methionine residue of rBclA was removed by a methionine aminopeptidase in *E. coli*.

![Formation of high-molecular-mass complexes containing cross-linked rBclA and rBxpB. Complexes were formed in reaction mixtures containing 20 µM rBclA and 5 µM rBxpB. Samples of purified rBclA and rBxpB and of rBclA-rBxpB cross-linked complexes were separately analyzed in triplicate by SDS-PAGE. The three essentially identical gels were used to detect proteins and protein complexes by immunoblotting with either an anti-BclA or an anti-BxpB MAb or by staining with Coomassie blue.](mbo0031111220004){#f4}

###### 

rBxpB fragments with attached amino-terminal peptides derived from rBclA*^[a](#ngt3.2)^*

  rBxpB residues   rBxpB sequence*^[b](#ngt3.2)^*
  ---------------- --------------------------------
  1--10            MFSS**D**CEFTK
  3--8             SSDC**E**F
  3--8             SS**D**C**E**F
  11--16           IDC**E**AK
  11--24           I**D**C**E**AKPASTLPAF
  11--26           I**D**CEAKPASTLPAFGF
  45--69           PSVSPNPNITVPVINDTVSVG**D**GIR
  60--69           **D**TVSVGDGIR
  87--97           **D**NSPVAPEAGR
  87--97           **D**NSPVAP**E**AGR
  87--98           **D**NSPVAP**E**AGRF
  92--97           AP**E**AGR
  118--134         SNVIGTG**E**VDVSSGVIL
  118--138         SNVIGTGEV**D**VSSGVILINLN
  138--144         NPG**D**LIR
  145--157         IVPV**E**LIGTVDIR
  145--157         IVPV**E**LIGTV**D**IR
  151--157         IGTV**D**IR

 Partial list showing 18 of 32 branched fragments.

 rBclA peptide attachment sites are in bold.

In the analysis of isopeptide bond formation *in vivo* and *in vitro*, samples were heated at 100°C prior to SDS-PAGE. Control experiments were performed demonstrating that the same isopeptide bonds were formed without heating (data not shown).

DISCUSSION {#h2}
==========

Isopeptide bond formation is a general posttranslational protein modification in which an amide linkage occurs between an amino group of one amino acid and a carboxyl group of a different amino acid, with one or both of the functional groups provided by an amino acid side chain. Isopeptide bonds are used to make proteins resistant to proteases ([@B16]), to stabilize protein structures ([@B17]), to attach proteins to cell surfaces ([@B18]), and to cross-link proteins in complex structures such as bacteriophage capsids ([@B19]), bacterial pili ([@B20]), and blood clots in humans ([@B21]). Isopeptide bonds can be formed enzymatically, or they can occur spontaneously between neighboring amino acids. Enzyme-catalyzed isopeptide bond formation involves the activation of the carboxyl group via an acyl-enzyme intermediate, followed by nucleophilic attack by a free amino group ([@B18], [@B22], [@B23]). Spontaneous isopeptide bond formation occurs when the reacting functional groups are aligned in close proximity within a reaction center that also includes a catalytic amino acid ([@B20], [@B24], [@B25]). In the examples of enzyme-catalyzed and spontaneous isopeptide bond formation described to date, the selection of the amino acids that participate in the formation of the covalent bond is typically highly specific ([@B20], [@B22], [@B24], [@B25]). This is especially true in the case of the amino acid that donates the carboxyl group, where selection appears to be absolutely specific. This constraint presumably reflects the need to activate the carboxyl group as the first step in the formation of both enzyme-catalyzed and spontaneous isopeptide bonds ([@B18], [@B20], [@B24], [@B26]).

The results presented in this study demonstrate that BclA attachment to the surface of *B. anthracis* spores occurs through the formation of isopeptide bonds to the exosporium basal layer protein BxpB. The mechanism of isopeptide bond formation in this case appears to be unlike any previously described mechanism. Our current results and those provided by recent related studies ([@B12], [@B13]) suggest the following model for BclA attachment to BxpB ([Fig. 5](#f5){ref-type="fig"}). Following the synthesis of BclA and BxpB in the mother cell, BclA forms glycosylated trimers and monomeric BxpB is incorporated into the outer region of the developing basal layer of the exosporium. Directed by its NTD localization signal(s), each strand of a BclA trimer binds to BxpB or perhaps to an adapter protein associated with BxpB. Up to three BclA NTDs can associate with a single molecule of BxpB ([Fig. 5A](#f5){ref-type="fig"}). Within this protein complex, the NTD of each strand of the BclA trimer is cleaved between residues S19 and A20 in a reaction catalyzed by a mother cell protease ([Fig. 5B](#f5){ref-type="fig"}). After cleavage, the amino group of BclA residue A20 is appropriately positioned to permit the formation of an isopeptide bond to 1 of 10 acidic residues in BxpB. Formation of this bond then occurs spontaneously ([Fig. 5C](#f5){ref-type="fig"}). The final reaction product includes up to three strands of the BclA trimer covalently linked to side chains of neighboring acidic amino acids of BxpB ([Fig. 5D](#f5){ref-type="fig"}).

![Model for the formation of isopeptide bonds that attach BclA to BxpB during exosporium assembly. (A) BclA NTD localization signals direct the binding of a BclA trimer to BxpB present in the basal layer of the exosporium. (B) Each NTD of a bound BclA trimer is proteolytically cleaved between residues S19 and A20, which produces a new and reactive amino terminus. The protein(s) required for cleavage remains to be identified. (C) The amino group of BclA residue A20 forms an isopeptide bond with an appropriately positioned side chain carboxyl group of an internal BxpB acidic residue. (D) Each strand of the BclA trimer can form an isopeptide bond with 1 of 10 acidic residues of BxpB, with each trimer presumably attaching to 3 neighboring acidic residues. There is no requirement, however, that all strands of the BclA trimer participate in isopeptide bond formation. The 13 acidic residues of BxpB are represented by red tick marks, and their positions within the protein are approximate.](mbo0031111220005){#f5}

The most unique aspects of this model are the requirement to generate a reactive amino group by proteolytic cleavage and the promiscuous selection of side chain carboxyl groups of BxpB acidic residues. The purpose of BclA NTD cleavage remains to be determined; however, our *in vitro* results suggest that its function is more than the positioning of residue A20 near a side chain carboxyl group of BxpB. One possibility is that cleavage is required to remove a nonreactive amino acid from the amino terminus of the NTD. Although the selection of the BxpB acidic residues is indeed promiscuous, it is not random. Three of the four most amino-terminal acidic residues of BxpB (i.e., D5, D12, and E14) do not appear to participate in the formation of isopeptide bonds to BclA *in vivo*. In fact, ongoing studies in our laboratory indicate that these three BxpB acidic residues, along with the only other acidic residue in the amino-terminal region (i.e., E7), are involved in the formation of isopeptide bonds with proteolytically processed amino termini of basal layer proteins ExsY and CotY during exosporium assembly (L. Tan and C. L. Turnbough, Jr., unpublished data). Interestingly, when purified rBclA and rBxpB are mixed together *in vitro*, rBclA-rBxpB complexes are formed that include isopeptide bonds involving all 13 acidic residues of BxpB. Evidently, in this case, the acidic residues near the amino terminus of BxpB can cross-link to BclA because they are not shielded by other exosporium proteins. Our model also includes the possible involvement of a BxpB-associated adaptor protein and a mother cell protease; however, currently there is no direct evidence for either factor and our *in vitro* studies suggest that an adapter protein, if present, would only be an accessory factor. Finally, a recent report by Thompson et al. ([@B27]) proposed that BclA is required for incorporation of BxpB into the exosporium, which would require modification of our model. However, studies in this laboratory have provided clear evidence that BxpB is readily incorporated into the *B. anthracis* exosporium in the absence of BclA ([@B10]). The failure of Thompson et al. to detect BxpB incorporation in the absence of BclA might be due to the inability of their experimental procedures to detect monomeric BxpB, which is the dominant form of BxpB extracted from spores lacking BclA.

Three observations suggest that the mechanism used to attach BclA to BxpB via isopeptide bond formation is a general mechanism of protein cross-linking. First, as mentioned above, BxpB appears to be cross-linked via isopeptide bonds to multiple exosporium basal layer proteins. The requirements for these cross-links appear to be the same as for isopeptide bond formation between BclA and BxpB. Second, a large number of collagenlike proteins in *Bacillus* species closely related to *B. anthracis* possess sequences in their NTDs that resemble BclA NTD sequences required for attachment to BxpB ([@B13]). At least one of these proteins is tightly attached to the exosporium ([@B12]), and the others are probably structural proteins involved in the formation of multiprotein complexes during sporulation. Finally, our model for the formation of isopeptide bonds between BclA and BxpB does not require factors that are necessarily species specific. It seems reasonable to expect, therefore, that analogous mechanisms of protein cross-linking will be found in many different types of organisms within all kingdoms of life. It is also noteworthy that BclA-BxpB cross-linking apparently relies only on short sequence motifs within the protein substrates. Therefore, it seems possible to use these motifs for the *in vitro* cross-linking of any proteins.

MATERIALS AND METHODS {#h3}
=====================

Bacterial strains and plasmids. {#h3.1}
-------------------------------

The Sterne 34F2 avirulent veterinary vaccine strain of *B. anthracis*, obtained from the U.S. Army Medical Research Institute of Infectious Diseases, Fort Detrick, MD, was used as the wild-type strain and as the parent in strain constructions. Strain CLT304 (*∆rmlD*) was a reconstruction of strain CLT274 ([@B5]). Strain CLT360 (*∆rmlD ∆bclA*) was constructed by inserting the *∆bclA* mutation from strain CLT292 ([@B5]) into the chromosome of strain CLT304 (*∆rmlD*) by phage CP51-mediated generalized transduction ([@B28]). Construction of strain CLT307 (*∆bxpB*) was previously described ([@B10]).

Construction of multicopy plasmid pCLT1525, which encodes a BclA NTD-eGFP fusion protein expressed from the *bclA* promoter, was previously described ([@B29]). To construct plasmids expressing wild-type or mutant *bxpB* genes, the two-gene *cotY-bxpB* operon (i.e., promoter, genes, and transcription terminator) was inserted into the cloning site of multicopy plasmid pCLT1474 ([@B30]). The DNA between the *cotY-bxpB* promoter region and the start codon of *bxpB*, including the entire *cotY* gene, was deleted by outward PCR ([@B5]). Up to 13 D/E-to-A point mutations were introduced into the wild-type *bxpB* gene of the recombinant plasmid by outward PCR. Each recombinant plasmid was introduced by electroporation into strain CLT307 (*∆bxpB*). All mutations and constructions were confirmed by PCR amplification of altered genetic loci and sequencing of the DNA products.

Preparation of spores and exosporia. {#h3.2}
------------------------------------

Spores were prepared by growing *B. anthracis* strains at 37°C on LB agar plates until sporulation was complete, typically for 3 to 4 days. Spores were washed from plates with cold (4°C) sterile water, collected by centrifugation, purified by sedimentation through a two-step gradient of 20% and 45% Isovue (Bracco Diagnostics), and washed extensively with cold sterile water. Spores were stored at 4°C in sterile water and quantitated spectrophotometrically at 580 nm as previously described ([@B31]). Exosporia were purified from spores as previously described ([@B9]).

Gel electrophoresis and immunoblotting. {#h3.3}
---------------------------------------

Spores (10^8^), exosporium samples, and purified proteins were boiled for 8 min in sample buffer containing 125 mM Tris-HCl (pH 6.8), 4% SDS, 100 mM dithiothreitol, 0.024% bromophenol blue, and 10% (vol/vol) glycerol. Solubilized proteins were separated by SDS-PAGE in a NuPAGE 4 to 12% bis-Tris gel (Invitrogen). For immunoblotting, spore proteins were transferred from a polyacrylamide gel to a nitrocellulose membrane and detected by staining as previously described ([@B9]). Purified anti-BclA (EF-12) and anti-BxpB (10-44-1) mouse MAbs were described previously ([@B13]), and the anti-GFP (GSN149) mouse MAb was purchased from Sigma. Intensity of staining was measured by densitometry.

Mass spectrometry. {#h3.4}
------------------

For protein analysis by MS, a Coomassie blue-stained protein band was sliced from a polyacrylamide gel and digested with trypsin and chymotrypsin ([@B15]). Proteolytic fragments were analyzed by LC-MS/MS with electrospray ionization using a Shimadzu NanoLC pump linked to an Applied Biosystems 4000 Qtrap mass spectrometer. Interpretation of spectra was performed manually with the aid of the Analyst 1.4.2 software with BioAnalyst extensions.

**Citation**Tan L, Li M, and Turnbough CL, Jr. 2011. An unusual mechanism of isopeptide bond formation attaches the collagenlike glycoprotein BclA to the exosporium of *Bacillus anthracis*. mBio 2(3):e00084-11. doi:10.1128/mBio.00084-11.

This work was supported by NIH grants AI81775 and AI57699.

We thank Landon Wilson in the University of Alabama at Birmingham Mass Spectrometry Core Facility for performing LC-MS/MS analyses.

We have filed a patent application related to work in this paper.

[^1]: Present address: Department of Neurology, University of Alabama at Birmingham, Birmingham, Alabama, USA.

[^2]: **Editor** Sankar Adhya, National Cancer Institute
